CNS Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $7.9M
Liabilities Breakdown FY2019
Total Liabilities: $311.0K
Asset Breakdown
Total Assets: $7.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.2M | 91.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $18.2K | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $652.6K | 8.2% |
Liabilities Breakdown
Total Liabilities: $311.0K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $243.7K | 78.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $67.3K | 21.7% |